The Indianapolis-based company expanded its spend to ensure it can meet growing demand for its weight-loss drugs.

Eli Lilly is committing to its roots, allocating $4.5 billion for new manufacturing investments across Indiana as drugmakers pledge more US projects.

The Indianapolis-based company expanded its spend to ensure it can meet growing demand for its weight-loss drugs.